CID 91668194

Mavelertinib

Structural Information

Molecular Formula
C18H22FN9O2
SMILES
CN1C=C(C(=N1)OC)NC2=C3C(=NC(=N2)N4C[C@H]([C@@H](C4)F)NC(=O)C=C)N(C=N3)C
InChI
InChI=1S/C18H22FN9O2/c1-5-13(29)21-11-8-28(6-10(11)19)18-23-15(14-16(24-18)26(2)9-20-14)22-12-7-27(3)25-17(12)30-4/h5,7,9-11H,1,6,8H2,2-4H3,(H,21,29)(H,22,23,24)/t10-,11-/m1/s1
InChIKey
JYIUNVOCEFIUIU-GHMZBOCLSA-N
Compound name
N-[(3R,4R)-4-fluoro-1-[6-[(3-methoxy-1-methylpyrazol-4-yl)amino]-9-methylpurin-2-yl]pyrrolidin-3-yl]prop-2-enamide
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

1
References

795
Patents

415.18805 Da
Monoisotopic Mass

1.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 416.19533 193.8
[M+Na]+ 438.17727 202.9
[M+NH4]+ 433.22187 195.9
[M+K]+ 454.15121 205.4
[M-H]- 414.18077 193.3
[M+Na-2H]- 436.16272 196.6
[M]+ 415.18750 194.3
[M]- 415.18860 194.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe